Bank of New York Mellon’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.42M | Buy |
12,725
+191
| +2% | +$32.8K | ﹤0.01% | 2836 |
|
|
2026
Q1 | $2.12M | Buy |
12,534
+690
| +6% | +$118K | ﹤0.01% | 2786 |
|
|
2025
Q4 | $2M | Buy |
11,844
+5,842
| +97% | +$949K | ﹤0.01% | 2833 |
|
|
2025
Q3 | $867K | Sell |
6,002
-701
| -10% | -$95.7K | ﹤0.01% | 3290 |
|
|
2025
Q2 | $848K | Sell |
6,703
-351
| -5% | -$43.1K | ﹤0.01% | 3214 |
|
|
2025
Q1 | $902K | Sell |
7,054
-467
| -6% | -$63.3K | ﹤0.01% | 3129 |
|
|
2024
Q4 | $994K | Sell |
7,521
-12,219
| -62% | -$1.72M | ﹤0.01% | 3169 |
|
|
2024
Q3 | $2.87M | Buy |
19,740
+27
| +0.1% | +$3.91K | ﹤0.01% | 2577 |
|
|
2024
Q2 | $2.71M | Sell |
19,713
-113
| -0.6% | -$15.1K | ﹤0.01% | 2630 |
|
|
2024
Q1 | $2.72M | Buy |
19,826
+599
| +3% | +$81.8K | ﹤0.01% | 2607 |
|
|
2023
Q4 | $2.61M | Sell |
19,227
-1,919
| -9% | -$234K | ﹤0.01% | 2697 |
|
|
2023
Q3 | $2.59M | Buy |
21,146
+716
| +4% | +$91.1K | ﹤0.01% | 2665 |
|
|
2023
Q2 | $2.59M | Sell |
20,430
-1,590
| -7% | -$207K | ﹤0.01% | 2687 |
|
|
2023
Q1 | $2.84M | Sell |
22,020
-1,322
| -6% | -$173K | ﹤0.01% | 2602 |
|
|
2022
Q4 | $3.06M | Sell |
23,342
-4,341
| -16% | -$561K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $3.24M | Buy |
27,683
+1,001
| +4% | +$124K | ﹤0.01% | 2541 |
|
|
2022
Q2 | $3.14M | Sell |
26,682
-1,651
| -6% | -$196K | ﹤0.01% | 2582 |
|
|
2022
Q1 | $3.69M | Sell |
28,333
-1,799
| -6% | -$234K | ﹤0.01% | 2582 |
|
|
2021
Q4 | $4.6M | Sell |
30,132
-1,640
| -5% | -$254K | ﹤0.01% | 2508 |
|
|
2021
Q3 | $5.14M | Buy |
31,772
+3,867
| +14% | +$651K | ﹤0.01% | 2472 |
|
|
2021
Q2 | $4.57M | Sell |
27,905
-1,026
| -4% | -$158K | ﹤0.01% | 2540 |
|
|
2021
Q1 | $4.36M | Sell |
28,931
-2,987
| -9% | -$474K | ﹤0.01% | 2500 |
|
|
2020
Q4 | $4.83M | Buy |
31,918
+813
| +3% | +$116K | ﹤0.01% | 2374 |
|
|
2020
Q3 | $4.21M | Sell |
31,105
-16,167
| -34% | -$2.19M | ﹤0.01% | 2307 |
|
|
2020
Q2 | $6.46M | Buy |
47,272
+11,594
| +32% | +$1.48M | ﹤0.01% | 2079 |
|
|
2020
Q1 | $3.84M | Sell |
35,678
-5,025
| -12% | -$579K | ﹤0.01% | 2213 |
|
|
2019
Q4 | $4.91M | Sell |
40,703
-1,241
| -3% | -$138K | ﹤0.01% | 2355 |
|
|
2019
Q3 | $4.17M | Sell |
41,944
-1,071
| -2% | -$112K | ﹤0.01% | 2372 |
|
|
2019
Q2 | $4.69M | Sell |
43,015
-1,076
| -2% | -$114K | ﹤0.01% | 2362 |
|
|
2019
Q1 | $4.93M | Sell |
44,091
-1,328
| -3% | -$146K | ﹤0.01% | 2338 |
|
|
2018
Q4 | $4.38M | Sell |
45,419
-2,505
| -5% | -$266K | ﹤0.01% | 2378 |
|
|
2018
Q3 | $5.84M | Sell |
47,924
-962
| -2% | -$113K | ﹤0.01% | 2331 |
|
|
2018
Q2 | $5.37M | Sell |
48,886
-3,849
| -7% | -$412K | ﹤0.01% | 2355 |
|
|
2018
Q1 | $5.63M | Buy |
52,735
+2,700
| +5% | +$299K | ﹤0.01% | 2291 |
|
|
2017
Q4 | $5.34M | Sell |
50,035
-1,064
| -2% | -$114K | ﹤0.01% | 2326 |
|
|
2017
Q3 | $5.68M | Sell |
51,099
-4,179
| -8% | -$447K | ﹤0.01% | 2281 |
|
|
2017
Q2 | $5.71M | Sell |
55,278
-4,884
| -8% | -$481K | ﹤0.01% | 2261 |
|
|
2017
Q1 | $5.88M | Sell |
60,162
-7,863
| -12% | -$753K | ﹤0.01% | 2251 |
|
|
2016
Q4 | $6.02M | Sell |
68,025
-44,751
| -40% | -$4.07M | ﹤0.01% | 2223 |
|
|
2016
Q3 | $10.9M | Sell |
112,776
-15,735
| -12% | -$1.5M | ﹤0.01% | 1836 |
|
|
2016
Q2 | $11M | Buy |
128,511
+5,619
| +5% | +$504K | ﹤0.01% | 1796 |
|
|
2016
Q1 | $10.7M | Buy |
122,892
+2,148
| +2% | +$192K | ﹤0.01% | 1802 |
|
|
2015
Q4 | $13.6M | Buy |
120,744
+792
| +0.7% | +$86K | ﹤0.01% | 1651 |
|
|
2015
Q3 | $12.1M | Buy |
119,952
+1,740
| +1% | +$209K | ﹤0.01% | 1746 |
|
|
2015
Q2 | $14.5M | Buy |
118,212
+5,913
| +5% | +$708K | ﹤0.01% | 1723 |
|
|
2015
Q1 | $12.9M | Buy |
112,299
+561
| +0.5% | +$61.9K | ﹤0.01% | 1807 |
|
|
2014
Q4 | $11.3M | Buy |
111,738
+17,787
| +19% | +$1.73M | ﹤0.01% | 1848 |
|
|
2014
Q3 | $8.57M | Buy |
93,951
+10,416
| +12% | +$914K | ﹤0.01% | 1993 |
|
|
2014
Q2 | $7.16M | Buy |
83,535
+12,459
| +18% | +$982K | ﹤0.01% | 2122 |
|
|
2014
Q1 | $5.6M | Buy |
71,076
+7,854
| +12% | +$654K | ﹤0.01% | 2255 |
|
|
2013
Q4 | $4.79M | Sell |
63,222
-1,728
| -3% | -$123K | ﹤0.01% | 2320 |
|
|
2013
Q3 | $4.54M | Buy |
64,950
+1,479
| +2% | +$96.9K | ﹤0.01% | 2305 |
|
|
2013
Q2 | $3.68M | Buy |
+63,471
| New | +$3.67M | ﹤0.01% | 2372 |
|
Other funds holding IBB
CB
WA
Bank of New York Mellon's IBB Position: Q2 2026 in Review
Bank of New York Mellon increased its iShares Biotechnology ETF (IBB) stake by 1.5% in Q2 2026, buying an estimated $32.8K and bringing the position to 12,725 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2836.
Bank of New York Mellon first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.5M in Q2 2015. 826 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Bank of New York Mellon held 12,725 shares of iShares Biotechnology ETF worth $2.42M as of Q2 2026.
- Bank of New York Mellon bought 191 iShares Biotechnology ETF shares in Q2 2026, an estimated $32.8K.
- iShares Biotechnology ETF made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2836 holding.
- Bank of New York Mellon first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's iShares Biotechnology ETF position peaked at $14.5M in Q2 2015.
- 826 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.